BioFinance and BioInnovate Europe 2008 is an unrivalled forum for accessing alternative financing options, strategically analysing licensing and M&A deals, commercialising innovation and building new business relationships and future partnerships.
Building on the success of our inaugural 2007 event, the BIA is very proud to launch BioInnovate Europe for 2008. BioInnovate conference sessions will focus on securing critical early stage funding and commercialising innovative technologies. It will bring together sessions, workshops and a trade show. This is also the annual event and showcase for BIA Fledgling Club Members. The Fledgling Club was established by the BIA in early 2008 with a clear objective of nurturing and assisting fledgling companies of today to become UK success stories of tomorrow.
"I am very pleased to be giving the keynote address at the BIA's BioFinance and BioInnovate Europe event. I know that the BIA works to improve the bioscience sector within the UK and this is an important event for addressing financing issues and looking at ways to drive and promote innovation. Clearly external partnerships between pharma and biotech are critical to the development of innovative medicines and this will be a key focus area during this event.".
Dr Patrick Vallance
Senior Vice President, Drug Discovery
GlaxoSmithKline
BioFinance and BioInnovate Europe 2008 Keynote Speaker
